CMAR_A_207167 6855..6869

1School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, Fujian Province, People’s Republic of China; 2Laboratory of Immuno-Oncology, Fujian Provincial Cancer Hospital, Fuzhou 350014, Fujian Province, People’s Republic of China; 3Department of Medical Oncology, Union Hospital of FujianMedical University, Fuzhou 350001, Fujian Province, People’s Republic of China; 4Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou 350014, Fujian Province, People’s Republic of China; 5Department of Pathology, Fujian Provincial Cancer Hospital, Fuzhou 350014, Fujian Province, People’s Republic of China; 6Department of Abdominal Surgery, Fujian Provincial Cancer Hospital, Fuzhou 350014, Fujian Province, People’s Republic of China

[1]  A. Snook,et al.  Immunotherapy regimens for metastatic colorectal carcinomas , 2017, Human vaccines & immunotherapeutics.

[2]  T. Pawełczyk,et al.  Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil. , 2017, Acta biochimica Polonica.

[3]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[4]  Ming-zhu Yin,et al.  siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells , 2017, Oncology letters.

[5]  C. Ross,et al.  Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention , 2016, Stem cells international.

[6]  R. Goldberg,et al.  Recent therapeutic advances in the treatment of colorectal cancer. , 2015, Annual review of medicine.

[7]  M. Jauberteau,et al.  Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells. , 2014, World journal of gastroenterology.

[8]  Klaus Pantel,et al.  Tumor metastasis: moving new biological insights into the clinic , 2013, Nature Medicine.

[9]  G. Botchkina.  Colon cancer stem cells--from basic to clinical application. , 2013, Cancer letters.

[10]  Shicai Chen,et al.  CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis , 2013, PloS one.

[11]  M. Kühl,et al.  On the role of Wnt/β-catenin signaling in stem cells. , 2013, Biochimica et biophysica acta.

[12]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[13]  R. Larsson,et al.  Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. , 2012, Experimental cell research.

[14]  A. Krešo,et al.  ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. , 2012, Cancer cell.

[15]  Y. Hu,et al.  Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. , 2012, The Annals of thoracic surgery.

[16]  R. Benezra,et al.  Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. , 2012, Stem cells and development.

[17]  F. Crea,et al.  Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  Hong Zhu,et al.  Expression and prognostic values of Id-1 and Id-3 in gastric adenocarcinoma. , 2011, The Journal of surgical research.

[19]  I. Wistuba,et al.  Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance , 2011, Clinical Cancer Research.

[20]  M. Tschan,et al.  The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. , 2011, Lung cancer.

[21]  L. Milas,et al.  Are cancer stem cells radioresistant? , 2010, Future oncology.

[22]  A. Gasbarrini,et al.  Post‐translational modulation of CD133 expression during sodium butyrate‐induced differentiation of HT29 human colon cancer cells: Implications for its detection , 2010, Journal of cellular physiology.

[23]  Y. Jeon,et al.  Id proteins facilitate self-renewal and proliferation of neural stem cells. , 2010, Stem cells and development.

[24]  E. Kondo,et al.  Characteristics of CD133+ Human Colon Cancer SW620 Cells , 2010, Cell transplantation.

[25]  Chris T. Harvey,et al.  ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21. , 2010, Cancer research.

[26]  W. Bodmer,et al.  Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.

[27]  Lin Zhang,et al.  KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer , 2009, Nature Cell Biology.

[28]  F. Crea,et al.  Cancer stem cell epigenetics and chemoresistance. , 2009, Epigenomics.

[29]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[30]  Y. Wong,et al.  The role of Id-1 in chemosensitivity and epirubicin-induced apoptosis in bladder cancer cells. , 2009, Oncology reports.

[31]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[32]  W. Woodward,et al.  Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework , 2009, Journal of Mammary Gland Biology and Neoplasia.

[33]  G. Kong,et al.  Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition , 2009, Oncogene.

[34]  R. Richardson,et al.  Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation , 2008, Nature.

[35]  Hong Zhang,et al.  Overexpression of Id-1 protein is a marker in colorectal cancer progression. , 2008, Oncology reports.

[36]  J. Carey,et al.  ID1‐, ID2‐, and ID3‐regulated gene expression in E2A positive or negative prostate cancer cells , 2007, The Prostate.

[37]  Y. Wong,et al.  Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. , 2007, Human pathology.

[38]  M. Katoh,et al.  Comparative genomics on PROM1 gene encoding stem cell marker CD133. , 2007, International journal of molecular medicine.

[39]  M. Henderson,et al.  CANCER STEM CELLS: A REVIEW , 2007, ANZ journal of surgery.

[40]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[41]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[42]  Xiaomeng Zhang,et al.  The multiple roles of Id-1 in cancer progression. , 2006, Differentiation; research in biological diversity.

[43]  Xiaomeng Zhang,et al.  Inactivation of Id‐1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway , 2006, International journal of cancer.

[44]  T. Takayama,et al.  Colorectal cancer: genetics of development and metastasis , 2006, Journal of Gastroenterology.

[45]  M. Schindl,et al.  Overexpression of Id‐1 is associated with poor clinical outcome in node negative breast cancer , 2003, International journal of cancer.

[46]  A. Iavarone,et al.  Id proteins at the cross-road of development and cancer , 2001, Oncogene.

[47]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[48]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.

[49]  Yannick D. Benoit.  Identification of Novel Molecules Targeting Cancer Stem Cells. , 2018, Methods in molecular biology.

[50]  A. Russo,et al.  Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer. , 2016, Advances in experimental medicine and biology.

[51]  Xiao-Hong Sun,et al.  Id proteins: small molecules, mighty regulators. , 2014, Current topics in developmental biology.

[52]  H. Wang,et al.  A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics. , 2012, Neoplasma.

[53]  A. Stembalska,et al.  Cancer stem cells: the theory and perspectives in cancer therapy , 2010, Journal of Applied Genetics.

[54]  S. Weiss,et al.  A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. , 2006, Nature cell biology.

[55]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.